nodes	percent_of_prediction	percent_of_DWPC	metapath
Carisoprodol—CYP2C19—prostate cancer	0.454	1	CbGaD
Carisoprodol—CYP2C19—Bicalutamide—prostate cancer	0.118	0.288	CbGbCtD
Carisoprodol—CYP2C19—Nilutamide—prostate cancer	0.118	0.288	CbGbCtD
Carisoprodol—CYP2C19—Flutamide—prostate cancer	0.0979	0.239	CbGbCtD
Carisoprodol—CYP2C19—Estradiol—prostate cancer	0.0406	0.0992	CbGbCtD
Carisoprodol—CYP2C19—Prednisone—prostate cancer	0.0349	0.0853	CbGbCtD
Carisoprodol—Meprobamate—CYP2E1—prostate cancer	0.00161	0.502	CrCbGaD
Carisoprodol—Meprobamate—CYP2C19—prostate cancer	0.00159	0.498	CrCbGaD
Carisoprodol—Irritability—Estrone—prostate cancer	0.00152	0.0168	CcSEcCtD
Carisoprodol—Pancytopenia—Estramustine—prostate cancer	0.00137	0.0151	CcSEcCtD
Carisoprodol—Irritability—Estradiol valerate/Dienogest—prostate cancer	0.00133	0.0147	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Cabazitaxel—prostate cancer	0.00114	0.0126	CcSEcCtD
Carisoprodol—Drowsiness—Flutamide—prostate cancer	0.00114	0.0126	CcSEcCtD
Carisoprodol—Flushing—Estramustine—prostate cancer	0.00107	0.0118	CcSEcCtD
Carisoprodol—Leukopenia—Estramustine—prostate cancer	0.000901	0.00995	CcSEcCtD
Carisoprodol—Viral infection—Estradiol—prostate cancer	0.0009	0.00994	CcSEcCtD
Carisoprodol—Back pain—Nilutamide—prostate cancer	0.000864	0.00954	CcSEcCtD
Carisoprodol—Irritability—Ethinyl Estradiol—prostate cancer	0.000864	0.00953	CcSEcCtD
Carisoprodol—Epigastric discomfort—Prednisone—prostate cancer	0.000859	0.00948	CcSEcCtD
Carisoprodol—Viral infection—Mitoxantrone—prostate cancer	0.000839	0.00926	CcSEcCtD
Carisoprodol—Flushing—Cabazitaxel—prostate cancer	0.000801	0.00884	CcSEcCtD
Carisoprodol—Syncope—Nilutamide—prostate cancer	0.000801	0.00884	CcSEcCtD
Carisoprodol—Leukopenia—Nilutamide—prostate cancer	0.000799	0.00882	CcSEcCtD
Carisoprodol—Leukopenia—Flutamide—prostate cancer	0.000796	0.00878	CcSEcCtD
Carisoprodol—Loss of consciousness—Nilutamide—prostate cancer	0.000785	0.00866	CcSEcCtD
Carisoprodol—Back pain—Degarelix—prostate cancer	0.000772	0.00852	CcSEcCtD
Carisoprodol—Insomnia—Estramustine—prostate cancer	0.000743	0.0082	CcSEcCtD
Carisoprodol—Back pain—Cabazitaxel—prostate cancer	0.000727	0.00802	CcSEcCtD
Carisoprodol—Insomnia—Abiraterone—prostate cancer	0.000721	0.00797	CcSEcCtD
Carisoprodol—Shock—Nilutamide—prostate cancer	0.000717	0.00792	CcSEcCtD
Carisoprodol—Irritability—Conjugated Estrogens—prostate cancer	0.000704	0.00777	CcSEcCtD
Carisoprodol—Dyspepsia—Abiraterone—prostate cancer	0.000702	0.00775	CcSEcCtD
Carisoprodol—Vertigo—Cabazitaxel—prostate cancer	0.000675	0.00745	CcSEcCtD
Carisoprodol—Leukopenia—Cabazitaxel—prostate cancer	0.000673	0.00743	CcSEcCtD
Carisoprodol—Insomnia—Nilutamide—prostate cancer	0.000659	0.00728	CcSEcCtD
Carisoprodol—Insomnia—Flutamide—prostate cancer	0.000656	0.00724	CcSEcCtD
Carisoprodol—Somnolence—Flutamide—prostate cancer	0.000645	0.00712	CcSEcCtD
Carisoprodol—Dyspepsia—Nilutamide—prostate cancer	0.000641	0.00708	CcSEcCtD
Carisoprodol—Back pain—Bicalutamide—prostate cancer	0.000623	0.00688	CcSEcCtD
Carisoprodol—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.000603	0.00665	CcSEcCtD
Carisoprodol—Tachycardia—Cabazitaxel—prostate cancer	0.000599	0.00661	CcSEcCtD
Carisoprodol—Insomnia—Degarelix—prostate cancer	0.000589	0.0065	CcSEcCtD
Carisoprodol—Syncope—Bicalutamide—prostate cancer	0.000578	0.00638	CcSEcCtD
Carisoprodol—Drowsiness—Goserelin—prostate cancer	0.000574	0.00633	CcSEcCtD
Carisoprodol—Loss of consciousness—Bicalutamide—prostate cancer	0.000567	0.00625	CcSEcCtD
Carisoprodol—Irritability—Estradiol—prostate cancer	0.000563	0.00622	CcSEcCtD
Carisoprodol—Dyspepsia—Cabazitaxel—prostate cancer	0.00054	0.00596	CcSEcCtD
Carisoprodol—Back pain—Ethinyl Estradiol—prostate cancer	0.000527	0.00582	CcSEcCtD
Carisoprodol—Vomiting—Estramustine—prostate cancer	0.000522	0.00577	CcSEcCtD
Carisoprodol—Dizziness—Estrone—prostate cancer	0.000519	0.00573	CcSEcCtD
Carisoprodol—Shock—Bicalutamide—prostate cancer	0.000518	0.00571	CcSEcCtD
Carisoprodol—Headache—Estramustine—prostate cancer	0.000515	0.00568	CcSEcCtD
Carisoprodol—Vomiting—Abiraterone—prostate cancer	0.000507	0.0056	CcSEcCtD
Carisoprodol—Hiccups—Capecitabine—prostate cancer	0.000507	0.0056	CcSEcCtD
Carisoprodol—Viral infection—Prednisone—prostate cancer	0.0005	0.00552	CcSEcCtD
Carisoprodol—Vomiting—Estrone—prostate cancer	0.000499	0.00551	CcSEcCtD
Carisoprodol—Headache—Estrone—prostate cancer	0.000491	0.00543	CcSEcCtD
Carisoprodol—Nausea—Estramustine—prostate cancer	0.000488	0.00539	CcSEcCtD
Carisoprodol—Dizziness—Nilutamide—prostate cancer	0.000482	0.00532	CcSEcCtD
Carisoprodol—Dizziness—Flutamide—prostate cancer	0.00048	0.0053	CcSEcCtD
Carisoprodol—Insomnia—Bicalutamide—prostate cancer	0.000476	0.00525	CcSEcCtD
Carisoprodol—Somnolence—Bicalutamide—prostate cancer	0.000468	0.00516	CcSEcCtD
Carisoprodol—Nausea—Estrone—prostate cancer	0.000466	0.00515	CcSEcCtD
Carisoprodol—Vomiting—Nilutamide—prostate cancer	0.000463	0.00512	CcSEcCtD
Carisoprodol—Dyspepsia—Bicalutamide—prostate cancer	0.000463	0.00511	CcSEcCtD
Carisoprodol—Vomiting—Flutamide—prostate cancer	0.000461	0.00509	CcSEcCtD
Carisoprodol—Headache—Nilutamide—prostate cancer	0.000457	0.00504	CcSEcCtD
Carisoprodol—Headache—Flutamide—prostate cancer	0.000454	0.00502	CcSEcCtD
Carisoprodol—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000453	0.005	CcSEcCtD
Carisoprodol—Hiccups—Prednisone—prostate cancer	0.000452	0.00499	CcSEcCtD
Carisoprodol—Pancytopenia—Mitoxantrone—prostate cancer	0.000451	0.00498	CcSEcCtD
Carisoprodol—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000435	0.00481	CcSEcCtD
Carisoprodol—Back pain—Goserelin—prostate cancer	0.000434	0.00479	CcSEcCtD
Carisoprodol—Nausea—Nilutamide—prostate cancer	0.000433	0.00478	CcSEcCtD
Carisoprodol—Nausea—Flutamide—prostate cancer	0.000431	0.00476	CcSEcCtD
Carisoprodol—Dizziness—Degarelix—prostate cancer	0.00043	0.00475	CcSEcCtD
Carisoprodol—Back pain—Conjugated Estrogens—prostate cancer	0.00043	0.00474	CcSEcCtD
Carisoprodol—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000429	0.00474	CcSEcCtD
Carisoprodol—Drowsiness—Mitoxantrone—prostate cancer	0.000424	0.00468	CcSEcCtD
Carisoprodol—Blood disorder—Epirubicin—prostate cancer	0.000423	0.00467	CcSEcCtD
Carisoprodol—Vomiting—Degarelix—prostate cancer	0.000414	0.00457	CcSEcCtD
Carisoprodol—Headache—Degarelix—prostate cancer	0.000408	0.0045	CcSEcCtD
Carisoprodol—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000407	0.00449	CcSEcCtD
Carisoprodol—Dizziness—Cabazitaxel—prostate cancer	0.000406	0.00448	CcSEcCtD
Carisoprodol—Leukopenia—Goserelin—prostate cancer	0.000401	0.00443	CcSEcCtD
Carisoprodol—Vertigo—Conjugated Estrogens—prostate cancer	0.000399	0.00441	CcSEcCtD
Carisoprodol—Syncope—Conjugated Estrogens—prostate cancer	0.000398	0.0044	CcSEcCtD
Carisoprodol—Blood disorder—Doxorubicin—prostate cancer	0.000391	0.00432	CcSEcCtD
Carisoprodol—Viral infection—Epirubicin—prostate cancer	0.000391	0.00432	CcSEcCtD
Carisoprodol—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.00039	0.00431	CcSEcCtD
Carisoprodol—Vomiting—Cabazitaxel—prostate cancer	0.00039	0.0043	CcSEcCtD
Carisoprodol—Convulsion—Goserelin—prostate cancer	0.000388	0.00429	CcSEcCtD
Carisoprodol—Nausea—Degarelix—prostate cancer	0.000387	0.00427	CcSEcCtD
Carisoprodol—Convulsion—Conjugated Estrogens—prostate cancer	0.000385	0.00425	CcSEcCtD
Carisoprodol—Headache—Cabazitaxel—prostate cancer	0.000384	0.00424	CcSEcCtD
Carisoprodol—Flushing—Estradiol—prostate cancer	0.000379	0.00418	CcSEcCtD
Carisoprodol—Pancytopenia—Etoposide—prostate cancer	0.000375	0.00415	CcSEcCtD
Carisoprodol—Nausea—Cabazitaxel—prostate cancer	0.000364	0.00402	CcSEcCtD
Carisoprodol—Viral infection—Doxorubicin—prostate cancer	0.000362	0.004	CcSEcCtD
Carisoprodol—Shock—Goserelin—prostate cancer	0.00036	0.00398	CcSEcCtD
Carisoprodol—Ataxia—Docetaxel—prostate cancer	0.000357	0.00395	CcSEcCtD
Carisoprodol—Tachycardia—Goserelin—prostate cancer	0.000357	0.00394	CcSEcCtD
Carisoprodol—Shock—Conjugated Estrogens—prostate cancer	0.000357	0.00394	CcSEcCtD
Carisoprodol—Tachycardia—Conjugated Estrogens—prostate cancer	0.000354	0.00391	CcSEcCtD
Carisoprodol—Hiccups—Epirubicin—prostate cancer	0.000353	0.0039	CcSEcCtD
Carisoprodol—Irritability—Capecitabine—prostate cancer	0.000351	0.00388	CcSEcCtD
Carisoprodol—Dizziness—Bicalutamide—prostate cancer	0.000348	0.00384	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Docetaxel—prostate cancer	0.000347	0.00383	CcSEcCtD
Carisoprodol—Ataxia—Capecitabine—prostate cancer	0.000346	0.00382	CcSEcCtD
Carisoprodol—Back pain—Estradiol—prostate cancer	0.000344	0.0038	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Capecitabine—prostate cancer	0.000336	0.00371	CcSEcCtD
Carisoprodol—Vomiting—Bicalutamide—prostate cancer	0.000334	0.00369	CcSEcCtD
Carisoprodol—Tremor—Estradiol—prostate cancer	0.000333	0.00368	CcSEcCtD
Carisoprodol—Insomnia—Goserelin—prostate cancer	0.000331	0.00365	CcSEcCtD
Carisoprodol—Headache—Bicalutamide—prostate cancer	0.00033	0.00364	CcSEcCtD
Carisoprodol—Insomnia—Conjugated Estrogens—prostate cancer	0.000328	0.00362	CcSEcCtD
Carisoprodol—Hiccups—Doxorubicin—prostate cancer	0.000327	0.00361	CcSEcCtD
Carisoprodol—Agitation—Estradiol—prostate cancer	0.000327	0.00361	CcSEcCtD
Carisoprodol—Somnolence—Goserelin—prostate cancer	0.000325	0.00359	CcSEcCtD
Carisoprodol—Somnolence—Conjugated Estrogens—prostate cancer	0.000322	0.00356	CcSEcCtD
Carisoprodol—Dyspepsia—Goserelin—prostate cancer	0.000322	0.00356	CcSEcCtD
Carisoprodol—Back pain—Mitoxantrone—prostate cancer	0.00032	0.00354	CcSEcCtD
Carisoprodol—Vertigo—Estradiol—prostate cancer	0.000319	0.00353	CcSEcCtD
Carisoprodol—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000319	0.00352	CcSEcCtD
Carisoprodol—Syncope—Estradiol—prostate cancer	0.000319	0.00352	CcSEcCtD
Carisoprodol—Irritability—Prednisone—prostate cancer	0.000313	0.00346	CcSEcCtD
Carisoprodol—Nausea—Bicalutamide—prostate cancer	0.000312	0.00345	CcSEcCtD
Carisoprodol—Loss of consciousness—Estradiol—prostate cancer	0.000312	0.00345	CcSEcCtD
Carisoprodol—Pancytopenia—Docetaxel—prostate cancer	0.000312	0.00345	CcSEcCtD
Carisoprodol—Pancytopenia—Capecitabine—prostate cancer	0.000302	0.00334	CcSEcCtD
Carisoprodol—Leukopenia—Mitoxantrone—prostate cancer	0.000296	0.00327	CcSEcCtD
Carisoprodol—Dizziness—Ethinyl Estradiol—prostate cancer	0.000294	0.00325	CcSEcCtD
Carisoprodol—Flushing—Etoposide—prostate cancer	0.000294	0.00324	CcSEcCtD
Carisoprodol—Convulsion—Mitoxantrone—prostate cancer	0.000287	0.00317	CcSEcCtD
Carisoprodol—Shock—Estradiol—prostate cancer	0.000285	0.00315	CcSEcCtD
Carisoprodol—Tachycardia—Estradiol—prostate cancer	0.000283	0.00313	CcSEcCtD
Carisoprodol—Vomiting—Ethinyl Estradiol—prostate cancer	0.000283	0.00312	CcSEcCtD
Carisoprodol—Headache—Ethinyl Estradiol—prostate cancer	0.000279	0.00308	CcSEcCtD
Carisoprodol—Back pain—Etoposide—prostate cancer	0.000266	0.00294	CcSEcCtD
Carisoprodol—Shock—Mitoxantrone—prostate cancer	0.000266	0.00294	CcSEcCtD
Carisoprodol—Nausea—Ethinyl Estradiol—prostate cancer	0.000264	0.00292	CcSEcCtD
Carisoprodol—Tachycardia—Mitoxantrone—prostate cancer	0.000264	0.00291	CcSEcCtD
Carisoprodol—Insomnia—Estradiol—prostate cancer	0.000262	0.0029	CcSEcCtD
Carisoprodol—Somnolence—Estradiol—prostate cancer	0.000258	0.00285	CcSEcCtD
Carisoprodol—Dyspepsia—Estradiol—prostate cancer	0.000255	0.00282	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	0.00025	0.00591	CbGpPWpGaD
Carisoprodol—Vertigo—Etoposide—prostate cancer	0.000248	0.00273	CcSEcCtD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.000247	0.00583	CbGpPWpGaD
Carisoprodol—Leukopenia—Etoposide—prostate cancer	0.000247	0.00272	CcSEcCtD
Carisoprodol—Flushing—Docetaxel—prostate cancer	0.000244	0.00269	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.000243	0.00574	CbGpPWpGaD
Carisoprodol—Loss of consciousness—Etoposide—prostate cancer	0.000242	0.00267	CcSEcCtD
Carisoprodol—Dizziness—Goserelin—prostate cancer	0.000242	0.00267	CcSEcCtD
Carisoprodol—Ataxia—Epirubicin—prostate cancer	0.000241	0.00266	CcSEcCtD
Carisoprodol—Somnolence—Mitoxantrone—prostate cancer	0.00024	0.00265	CcSEcCtD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.00024	0.00566	CbGpPWpGaD
Carisoprodol—Dizziness—Conjugated Estrogens—prostate cancer	0.00024	0.00265	CcSEcCtD
Carisoprodol—Convulsion—Etoposide—prostate cancer	0.000239	0.00264	CcSEcCtD
Carisoprodol—Dyspepsia—Mitoxantrone—prostate cancer	0.000238	0.00263	CcSEcCtD
Carisoprodol—Flushing—Capecitabine—prostate cancer	0.000236	0.00261	CcSEcCtD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000235	0.00555	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—HPGDS—prostate cancer	0.000235	0.00553	CbGpPWpGaD
Carisoprodol—Orthostatic hypotension—Epirubicin—prostate cancer	0.000234	0.00259	CcSEcCtD
Carisoprodol—Vomiting—Goserelin—prostate cancer	0.000233	0.00257	CcSEcCtD
Carisoprodol—Vomiting—Conjugated Estrogens—prostate cancer	0.00023	0.00254	CcSEcCtD
Carisoprodol—Headache—Goserelin—prostate cancer	0.000229	0.00253	CcSEcCtD
Carisoprodol—Headache—Conjugated Estrogens—prostate cancer	0.000227	0.00251	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—UGT2B17—prostate cancer	0.000224	0.00528	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—UGT2B15—prostate cancer	0.000224	0.00528	CbGpPWpGaD
Carisoprodol—Ataxia—Doxorubicin—prostate cancer	0.000223	0.00246	CcSEcCtD
Carisoprodol—Back pain—Docetaxel—prostate cancer	0.000221	0.00245	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000221	0.00522	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—UGT2B17—prostate cancer	0.000221	0.0052	CbGpPWpGaD
Carisoprodol—Tachycardia—Etoposide—prostate cancer	0.000219	0.00242	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—AKR1C3—prostate cancer	0.000219	0.00516	CbGpPWpGaD
Carisoprodol—Nausea—Goserelin—prostate cancer	0.000217	0.0024	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000217	0.00239	CcSEcCtD
Carisoprodol—Nausea—Conjugated Estrogens—prostate cancer	0.000215	0.00238	CcSEcCtD
Carisoprodol—Back pain—Capecitabine—prostate cancer	0.000214	0.00237	CcSEcCtD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—CYP1A1—prostate cancer	0.000213	0.00501	CbGpPWpGaD
Carisoprodol—Flushing—Prednisone—prostate cancer	0.000211	0.00232	CcSEcCtD
Carisoprodol—Pancytopenia—Epirubicin—prostate cancer	0.00021	0.00232	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—GSTM3—prostate cancer	0.00021	0.00496	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—SULT2B1—prostate cancer	0.00021	0.00496	CbGpPWpGaD
Carisoprodol—Tremor—Capecitabine—prostate cancer	0.000208	0.00229	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—SULT2B1—prostate cancer	0.000207	0.00489	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTM3—prostate cancer	0.000207	0.00489	CbGpPWpGaD
Carisoprodol—Syncope—Docetaxel—prostate cancer	0.000205	0.00227	CcSEcCtD
Carisoprodol—Leukopenia—Docetaxel—prostate cancer	0.000205	0.00226	CcSEcCtD
Carisoprodol—Loss of consciousness—Docetaxel—prostate cancer	0.000201	0.00222	CcSEcCtD
Carisoprodol—Somnolence—Etoposide—prostate cancer	0.0002	0.00221	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—NAT1—prostate cancer	0.000199	0.0047	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP3A43—prostate cancer	0.000199	0.0047	CbGpPWpGaD
Carisoprodol—Vertigo—Capecitabine—prostate cancer	0.000199	0.0022	CcSEcCtD
Carisoprodol—Syncope—Capecitabine—prostate cancer	0.000199	0.00219	CcSEcCtD
Carisoprodol—Leukopenia—Capecitabine—prostate cancer	0.000198	0.00219	CcSEcCtD
Carisoprodol—Convulsion—Docetaxel—prostate cancer	0.000198	0.00219	CcSEcCtD
Carisoprodol—Drowsiness—Epirubicin—prostate cancer	0.000198	0.00218	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	0.000197	0.00465	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP3A43—prostate cancer	0.000197	0.00464	CbGpPWpGaD
Carisoprodol—Loss of consciousness—Capecitabine—prostate cancer	0.000195	0.00215	CcSEcCtD
Carisoprodol—Pancytopenia—Doxorubicin—prostate cancer	0.000195	0.00215	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	0.000194	0.00459	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	0.000192	0.00453	CbGpPWpGaD
Carisoprodol—Dizziness—Estradiol—prostate cancer	0.000192	0.00212	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	0.000186	0.00439	CbGpPWpGaD
Carisoprodol—Vomiting—Estradiol—prostate cancer	0.000184	0.00204	CcSEcCtD
Carisoprodol—Shock—Docetaxel—prostate cancer	0.000184	0.00203	CcSEcCtD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.000184	0.00433	CbGpPWpGaD
Carisoprodol—Drowsiness—Doxorubicin—prostate cancer	0.000183	0.00202	CcSEcCtD
Carisoprodol—Tachycardia—Docetaxel—prostate cancer	0.000182	0.00201	CcSEcCtD
Carisoprodol—Headache—Estradiol—prostate cancer	0.000182	0.00201	CcSEcCtD
Carisoprodol—Agitation—Prednisone—prostate cancer	0.000181	0.002	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—CYP1B1—prostate cancer	0.000181	0.00428	CbGpPWpGaD
Carisoprodol—Shock—Capecitabine—prostate cancer	0.000178	0.00197	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	0.000177	0.00418	CbGpPWpGaD
Carisoprodol—Vertigo—Prednisone—prostate cancer	0.000177	0.00196	CcSEcCtD
Carisoprodol—Syncope—Prednisone—prostate cancer	0.000177	0.00195	CcSEcCtD
Carisoprodol—Tachycardia—Capecitabine—prostate cancer	0.000177	0.00195	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—GGT1—prostate cancer	0.000176	0.00414	CbGpPWpGaD
Carisoprodol—Loss of consciousness—Prednisone—prostate cancer	0.000174	0.00192	CcSEcCtD
Carisoprodol—Nausea—Estradiol—prostate cancer	0.000172	0.0019	CcSEcCtD
Carisoprodol—Vomiting—Mitoxantrone—prostate cancer	0.000172	0.0019	CcSEcCtD
Carisoprodol—Convulsion—Prednisone—prostate cancer	0.000171	0.00189	CcSEcCtD
Carisoprodol—Headache—Mitoxantrone—prostate cancer	0.000169	0.00187	CcSEcCtD
Carisoprodol—Insomnia—Docetaxel—prostate cancer	0.000169	0.00187	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—EPHX1—prostate cancer	0.000167	0.00394	CbGpPWpGaD
Carisoprodol—Somnolence—Docetaxel—prostate cancer	0.000166	0.00183	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	0.000165	0.0039	CbGpPWpGaD
Carisoprodol—Flushing—Epirubicin—prostate cancer	0.000165	0.00182	CcSEcCtD
Carisoprodol—Dyspepsia—Docetaxel—prostate cancer	0.000164	0.00182	CcSEcCtD
Carisoprodol—Insomnia—Capecitabine—prostate cancer	0.000164	0.00181	CcSEcCtD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	0.000163	0.00385	CbGpPWpGaD
Carisoprodol—Nausea—Mitoxantrone—prostate cancer	0.000161	0.00177	CcSEcCtD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—GSK3B—prostate cancer	0.00016	0.00377	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—prostate cancer	0.000159	0.00376	CbGpPWpGaD
Carisoprodol—Dyspepsia—Capecitabine—prostate cancer	0.000159	0.00176	CcSEcCtD
Carisoprodol—Shock—Prednisone—prostate cancer	0.000159	0.00175	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	0.000158	0.00372	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.000157	0.00371	CbGpPWpGaD
Carisoprodol—Tachycardia—Prednisone—prostate cancer	0.000157	0.00174	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	0.000157	0.0037	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP7B1—prostate cancer	0.000155	0.00366	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000155	0.00365	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP7B1—prostate cancer	0.000153	0.00361	CbGpPWpGaD
Carisoprodol—Flushing—Doxorubicin—prostate cancer	0.000152	0.00168	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—SULT1E1—prostate cancer	0.000151	0.00356	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.000151	0.00356	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.00015	0.00353	CbGpPWpGaD
Carisoprodol—Back pain—Epirubicin—prostate cancer	0.000149	0.00165	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—SULT1E1—prostate cancer	0.000149	0.00351	CbGpPWpGaD
Carisoprodol—Dizziness—Etoposide—prostate cancer	0.000149	0.00164	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	0.000147	0.00348	CbGpPWpGaD
Carisoprodol—Insomnia—Prednisone—prostate cancer	0.000146	0.00161	CcSEcCtD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.000145	0.00343	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000144	0.00339	CbGpPWpGaD
Carisoprodol—Vomiting—Etoposide—prostate cancer	0.000143	0.00158	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000142	0.00335	CbGpPWpGaD
Carisoprodol—Agitation—Epirubicin—prostate cancer	0.000142	0.00157	CcSEcCtD
Carisoprodol—Dyspepsia—Prednisone—prostate cancer	0.000142	0.00157	CcSEcCtD
Carisoprodol—Headache—Etoposide—prostate cancer	0.000141	0.00156	CcSEcCtD
Carisoprodol—Vertigo—Epirubicin—prostate cancer	0.000139	0.00153	CcSEcCtD
Carisoprodol—Syncope—Epirubicin—prostate cancer	0.000138	0.00153	CcSEcCtD
Carisoprodol—Leukopenia—Epirubicin—prostate cancer	0.000138	0.00153	CcSEcCtD
Carisoprodol—Back pain—Doxorubicin—prostate cancer	0.000138	0.00153	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—CYP1A1—prostate cancer	0.000137	0.00324	CbGpPWpGaD
Carisoprodol—Loss of consciousness—Epirubicin—prostate cancer	0.000136	0.0015	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000134	0.00316	CbGpPWpGaD
Carisoprodol—Convulsion—Epirubicin—prostate cancer	0.000134	0.00148	CcSEcCtD
Carisoprodol—Nausea—Etoposide—prostate cancer	0.000134	0.00147	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—CYP3A5—prostate cancer	0.000133	0.00314	CbGpPWpGaD
Carisoprodol—Agitation—Doxorubicin—prostate cancer	0.000131	0.00145	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP3A5—prostate cancer	0.000131	0.00309	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000129	0.00305	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA3—prostate cancer	0.000128	0.00303	CbGpPWpGaD
Carisoprodol—Vertigo—Doxorubicin—prostate cancer	0.000128	0.00142	CcSEcCtD
Carisoprodol—Syncope—Doxorubicin—prostate cancer	0.000128	0.00141	CcSEcCtD
Carisoprodol—Leukopenia—Doxorubicin—prostate cancer	0.000128	0.00141	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.000127	0.003	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTA3—prostate cancer	0.000127	0.00299	CbGpPWpGaD
Carisoprodol—Loss of consciousness—Doxorubicin—prostate cancer	0.000126	0.00139	CcSEcCtD
Carisoprodol—Shock—Epirubicin—prostate cancer	0.000124	0.00137	CcSEcCtD
Carisoprodol—Convulsion—Doxorubicin—prostate cancer	0.000124	0.00137	CcSEcCtD
Carisoprodol—Dizziness—Docetaxel—prostate cancer	0.000124	0.00136	CcSEcCtD
Carisoprodol—Tachycardia—Epirubicin—prostate cancer	0.000123	0.00136	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000121	0.00286	CbGpPWpGaD
Carisoprodol—Dizziness—Capecitabine—prostate cancer	0.00012	0.00132	CcSEcCtD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.000119	0.00282	CbGpPWpGaD
Carisoprodol—Vomiting—Docetaxel—prostate cancer	0.000119	0.00131	CcSEcCtD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.000119	0.0028	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA4—prostate cancer	0.000118	0.00277	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—TBXAS1—prostate cancer	0.000118	0.00277	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000117	0.00276	CbGpPWpGaD
Carisoprodol—Headache—Docetaxel—prostate cancer	0.000117	0.00129	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTA4—prostate cancer	0.000116	0.00273	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000115	0.00272	CbGpPWpGaD
Carisoprodol—Vomiting—Capecitabine—prostate cancer	0.000115	0.00127	CcSEcCtD
Carisoprodol—Shock—Doxorubicin—prostate cancer	0.000115	0.00127	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—GSTA2—prostate cancer	0.000115	0.0027	CbGpPWpGaD
Carisoprodol—Insomnia—Epirubicin—prostate cancer	0.000114	0.00126	CcSEcCtD
Carisoprodol—Tachycardia—Doxorubicin—prostate cancer	0.000114	0.00126	CcSEcCtD
Carisoprodol—Headache—Capecitabine—prostate cancer	0.000113	0.00125	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—SULT1A1—prostate cancer	0.000113	0.00267	CbGpPWpGaD
Carisoprodol—Somnolence—Epirubicin—prostate cancer	0.000112	0.00124	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—SULT1A1—prostate cancer	0.000112	0.00263	CbGpPWpGaD
Carisoprodol—Nausea—Docetaxel—prostate cancer	0.000111	0.00123	CcSEcCtD
Carisoprodol—Dyspepsia—Epirubicin—prostate cancer	0.000111	0.00122	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—GSTA1—prostate cancer	0.00011	0.00261	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—NAT2—prostate cancer	0.000109	0.00258	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTO1—prostate cancer	0.000109	0.00258	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—NAT2—prostate cancer	0.000108	0.00254	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTO1—prostate cancer	0.000108	0.00254	CbGpPWpGaD
Carisoprodol—Nausea—Capecitabine—prostate cancer	0.000107	0.00119	CcSEcCtD
Carisoprodol—Dizziness—Prednisone—prostate cancer	0.000107	0.00118	CcSEcCtD
Carisoprodol—Insomnia—Doxorubicin—prostate cancer	0.000105	0.00116	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—CYP2C18—prostate cancer	0.000105	0.00247	CbGpPWpGaD
Carisoprodol—Somnolence—Doxorubicin—prostate cancer	0.000104	0.00114	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP2C18—prostate cancer	0.000103	0.00244	CbGpPWpGaD
Carisoprodol—Dyspepsia—Doxorubicin—prostate cancer	0.000103	0.00113	CcSEcCtD
Carisoprodol—Vomiting—Prednisone—prostate cancer	0.000102	0.00113	CcSEcCtD
Carisoprodol—Headache—Prednisone—prostate cancer	0.000101	0.00111	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—SULT2A1—prostate cancer	9.74e-05	0.0023	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	9.63e-05	0.00227	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—SULT2A1—prostate cancer	9.6e-05	0.00227	CbGpPWpGaD
Carisoprodol—Nausea—Prednisone—prostate cancer	9.57e-05	0.00106	CcSEcCtD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	9.24e-05	0.00218	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	9.24e-05	0.00218	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GPX3—prostate cancer	9.16e-05	0.00216	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—HPGDS—prostate cancer	8.73e-05	0.00206	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTT1—prostate cancer	8.47e-05	0.002	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP2A6—prostate cancer	8.37e-05	0.00197	CbGpPWpGaD
Carisoprodol—Dizziness—Epirubicin—prostate cancer	8.33e-05	0.00092	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—PTGS2—prostate cancer	8.17e-05	0.00193	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	8.08e-05	0.0019	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—AKR1C3—prostate cancer	8.03e-05	0.00189	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP17A1—prostate cancer	8.02e-05	0.00189	CbGpPWpGaD
Carisoprodol—Vomiting—Epirubicin—prostate cancer	8.01e-05	0.000885	CcSEcCtD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP17A1—prostate cancer	7.91e-05	0.00187	CbGpPWpGaD
Carisoprodol—Headache—Epirubicin—prostate cancer	7.9e-05	0.000872	CcSEcCtD
Carisoprodol—Dizziness—Doxorubicin—prostate cancer	7.71e-05	0.000851	CcSEcCtD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	7.66e-05	0.00181	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	7.66e-05	0.00181	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	7.66e-05	0.00181	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—NCOA2—prostate cancer	7.64e-05	0.0018	CbGpPWpGaD
Carisoprodol—Nausea—Epirubicin—prostate cancer	7.49e-05	0.000827	CcSEcCtD
Carisoprodol—Vomiting—Doxorubicin—prostate cancer	7.41e-05	0.000819	CcSEcCtD
Carisoprodol—Headache—Doxorubicin—prostate cancer	7.31e-05	0.000807	CcSEcCtD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	7.3e-05	0.00172	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP2E1—prostate cancer	7.12e-05	0.00168	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP2E1—prostate cancer	7.02e-05	0.00166	CbGpPWpGaD
Carisoprodol—Nausea—Doxorubicin—prostate cancer	6.93e-05	0.000765	CcSEcCtD
Carisoprodol—CYP2C19—Biological oxidations—CYP3A4—prostate cancer	6.87e-05	0.00162	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP3A4—prostate cancer	6.77e-05	0.0016	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP1B1—prostate cancer	6.75e-05	0.00159	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP1B1—prostate cancer	6.66e-05	0.00157	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GGT1—prostate cancer	6.54e-05	0.00154	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	6.51e-05	0.00154	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—NCOA1—prostate cancer	6.44e-05	0.00152	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP19A1—prostate cancer	6.35e-05	0.0015	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP19A1—prostate cancer	6.26e-05	0.00148	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—RXRA—prostate cancer	6.12e-05	0.00144	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	6.12e-05	0.00144	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	5.95e-05	0.0014	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—COMT—prostate cancer	5.9e-05	0.00139	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTP1—prostate cancer	5.87e-05	0.00138	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—COMT—prostate cancer	5.82e-05	0.00137	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	5.8e-05	0.00137	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTP1—prostate cancer	5.79e-05	0.00137	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	5.54e-05	0.00131	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	5.54e-05	0.00131	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTM1—prostate cancer	5.4e-05	0.00127	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTM1—prostate cancer	5.32e-05	0.00126	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP1A1—prostate cancer	5.12e-05	0.00121	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HAO1—prostate cancer	5.05e-05	0.00119	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP1A1—prostate cancer	5.05e-05	0.00119	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	4.71e-05	0.00111	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	4.51e-05	0.00106	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	4.34e-05	0.00102	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	4.2e-05	0.000989	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GRHL1—prostate cancer	4.12e-05	0.000971	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CSAD—prostate cancer	4.12e-05	0.000971	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CBR1—prostate cancer	4.12e-05	0.000971	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TST—prostate cancer	4.12e-05	0.000971	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ADI1—prostate cancer	4.12e-05	0.000971	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PSAT1—prostate cancer	4.12e-05	0.000971	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.02e-05	0.000949	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	3.94e-05	0.00093	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GRHPR—prostate cancer	3.83e-05	0.000902	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CKMT2—prostate cancer	3.83e-05	0.000902	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—UGT2B15—prostate cancer	3.83e-05	0.000902	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—UGT2B17—prostate cancer	3.83e-05	0.000902	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	3.74e-05	0.000882	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—MED12—prostate cancer	3.68e-05	0.000868	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—RFK—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AOX1—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTM3—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SULT2B1—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PGAM2—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NAGLU—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MBTPS1—prostate cancer	3.6e-05	0.000848	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.52e-05	0.000829	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP3A43—prostate cancer	3.41e-05	0.000804	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AMACR—prostate cancer	3.41e-05	0.000804	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NAT1—prostate cancer	3.41e-05	0.000804	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SRD5A2—prostate cancer	3.41e-05	0.000804	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—DEGS1—prostate cancer	3.41e-05	0.000804	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.35e-05	0.000791	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HSD17B1—prostate cancer	3.25e-05	0.000767	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.25e-05	0.000767	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.13e-05	0.000738	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.11e-05	0.000734	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.08e-05	0.000726	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.93e-05	0.000692	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—B4GALT4—prostate cancer	2.9e-05	0.000684	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HPGD—prostate cancer	2.9e-05	0.000684	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TNFRSF21—prostate cancer	2.73e-05	0.000643	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP7B1—prostate cancer	2.65e-05	0.000625	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MTAP—prostate cancer	2.65e-05	0.000625	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.59e-05	0.000611	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SRD5A1—prostate cancer	2.58e-05	0.000609	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SULT1E1—prostate cancer	2.58e-05	0.000609	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.51e-05	0.000592	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.47e-05	0.000583	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ACSL4—prostate cancer	2.47e-05	0.000581	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HSD17B3—prostate cancer	2.47e-05	0.000581	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.44e-05	0.000575	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ARG2—prostate cancer	2.36e-05	0.000557	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—UMPS—prostate cancer	2.36e-05	0.000557	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PHGDH—prostate cancer	2.36e-05	0.000557	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.35e-05	0.000555	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—LDHB—prostate cancer	2.32e-05	0.000547	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP3A5—prostate cancer	2.28e-05	0.000537	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PDHA1—prostate cancer	2.2e-05	0.000518	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA3—prostate cancer	2.2e-05	0.000518	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TCN2—prostate cancer	2.2e-05	0.000518	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—UCP3—prostate cancer	2.2e-05	0.000518	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC22A3—prostate cancer	2.1e-05	0.000494	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HSD3B1—prostate cancer	2.1e-05	0.000494	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.03e-05	0.00048	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TBXAS1—prostate cancer	2.01e-05	0.000474	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA4—prostate cancer	2.01e-05	0.000474	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.96e-05	0.000463	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA2—prostate cancer	1.96e-05	0.000462	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SULT1A1—prostate cancer	1.93e-05	0.000456	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCG5—prostate cancer	1.93e-05	0.000456	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA1—prostate cancer	1.89e-05	0.000446	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTO1—prostate cancer	1.87e-05	0.000441	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HSD3B2—prostate cancer	1.87e-05	0.000441	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NAT2—prostate cancer	1.87e-05	0.000441	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.8e-05	0.000424	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PLCB2—prostate cancer	1.79e-05	0.000422	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—LRP2—prostate cancer	1.79e-05	0.000422	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2C18—prostate cancer	1.79e-05	0.000422	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—P4HB—prostate cancer	1.76e-05	0.000414	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC22A1—prostate cancer	1.71e-05	0.000403	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.69e-05	0.000398	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SULT2A1—prostate cancer	1.67e-05	0.000393	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MED12—prostate cancer	1.64e-05	0.000386	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GNG5—prostate cancer	1.63e-05	0.000383	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA3—prostate cancer	1.57e-05	0.000369	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.54e-05	0.000363	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HPGDS—prostate cancer	1.49e-05	0.000352	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTT1—prostate cancer	1.45e-05	0.000342	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ACHE—prostate cancer	1.45e-05	0.000342	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2A6—prostate cancer	1.43e-05	0.000338	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.43e-05	0.000336	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AKR1C3—prostate cancer	1.39e-05	0.000329	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PRKACB—prostate cancer	1.39e-05	0.000327	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP17A1—prostate cancer	1.37e-05	0.000323	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.35e-05	0.000319	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA2—prostate cancer	1.31e-05	0.000308	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC5A5—prostate cancer	1.25e-05	0.000294	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2E1—prostate cancer	1.22e-05	0.000287	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NQO1—prostate cancer	1.2e-05	0.000284	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TH—prostate cancer	1.19e-05	0.00028	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.18e-05	0.000278	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.17e-05	0.000277	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.17e-05	0.000275	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.15e-05	0.000272	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GGT1—prostate cancer	1.12e-05	0.000264	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA1—prostate cancer	1.1e-05	0.00026	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.09e-05	0.000256	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—RXRA—prostate cancer	1.05e-05	0.000247	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.02e-05	0.00024	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—COMT—prostate cancer	1.01e-05	0.000238	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTP1—prostate cancer	1e-05	0.000237	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ITPR1—prostate cancer	9.88e-06	0.000233	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.72e-06	0.000229	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TYMS—prostate cancer	9.34e-06	0.00022	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTM1—prostate cancer	9.23e-06	0.000218	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—LPL—prostate cancer	9.06e-06	0.000214	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP1A1—prostate cancer	8.75e-06	0.000206	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ERCC2—prostate cancer	8.68e-06	0.000205	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MTHFR—prostate cancer	8.16e-06	0.000192	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PPARA—prostate cancer	8e-06	0.000189	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CAV1—prostate cancer	7.52e-06	0.000177	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.19e-06	0.000169	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CG—prostate cancer	6.85e-06	0.000162	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—INS—prostate cancer	6.49e-06	0.000153	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CREBBP—prostate cancer	6.35e-06	0.00015	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CD—prostate cancer	6.02e-06	0.000142	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NOS3—prostate cancer	5.69e-06	0.000134	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CB—prostate cancer	5.25e-06	0.000124	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTGS2—prostate cancer	5.2e-06	0.000123	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTEN—prostate cancer	4.54e-06	0.000107	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—EP300—prostate cancer	4.33e-06	0.000102	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.2e-06	7.55e-05	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AKT1—prostate cancer	2.61e-06	6.17e-05	CbGpPWpGaD
